OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Covid‐19 and Liver Injury: Role of Inflammatory Endotheliopathy, Platelet Dysfunction, and Thrombosis
Matthew J. McConnell, Reiichiro Kondo, Nao Kawaguchi, et al.
Hepatology Communications (2021) Vol. 6, Iss. 2, pp. 255-269
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

Histopathological Features of SARS-CoV-2 in Extrapulmonary Organ Infection: A Systematic Review of Literature
Diana Torge, Sara Bernardi, Mauro Arcangeli, et al.
Pathogens (2022) Vol. 11, Iss. 8, pp. 867-867
Open Access | Times Cited: 40

Pathogenesis and Mechanisms of SARS-CoV-2 Infection in the Intestine, Liver, and Pancreas
Zaid Khreefa, Mallory T. Barbier, Ali Rıza Köksal, et al.
Cells (2023) Vol. 12, Iss. 2, pp. 262-262
Open Access | Times Cited: 28

Scavenging ROS to Alleviate Acute Liver Injury by ZnO‐NiO@COOH
Xuan Wu, Shiyu Liu, Huanhuan Zhu, et al.
Advanced Science (2022) Vol. 9, Iss. 11
Open Access | Times Cited: 31

The FIB-4 scores in the emergency department to predict the outcomes of COVID-19 patients in taiwan
Chia-Yu Liu, San-Fang Chou, Pei-Ying Chiang, et al.
Heliyon (2024) Vol. 10, Iss. 4, pp. e25649-e25649
Open Access | Times Cited: 6

COVID-19 and liver disease: where are we now?
Francesco Paolo Russo, Patrizia Burra, Alberto Zanetto
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 19, Iss. 5, pp. 277-278
Open Access | Times Cited: 26

Histopathological impact of SARS-CoV-2 on the liver: Cellular damage and long-term complications
Alfonso Rodriguez-Espada, Moisés Salgado-de la Mora, Briana Mariette Rodriguez-Paniagua, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 22, pp. 2866-2880
Open Access | Times Cited: 5

COVID-19 and hepatic injury: Diversity and risk assessment
Fares E.M. Ali, Mostafa K Abd El-Aziz, Mahmoud Ali, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 3, pp. 425-449
Open Access | Times Cited: 12

Disease Severity in Moderate-to-Severe COVID-19 Is Associated With Platelet Hyperreactivity and Innate Immune Activation
Kai Jakobs, Leander Reinshagen, Marianna Puccini, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18

SARS-CoV-2 Establishes a Productive Infection in Hepatoma and Glioblastoma Multiforme Cell Lines
Olga A. Smirnova, Olga N. Ivanova, Irina T. Fedyakina, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 632-632
Open Access | Times Cited: 10

Effect of COVID-19 Pandemic on Patients Who Have Undergone Liver Transplantation: Retrospective Cohort Study
Sami Akbulut, Fatma Hilal Yağın, Tevfik Tolga Şahin, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 13, pp. 4466-4466
Open Access | Times Cited: 10

SARS-CoV-2 outbreak: role of viral proteins and genomic diversity in virus infection and COVID-19 progression
Hosni A. M. Hussein, Ali A. Thabet, Ahmed A. Wardany, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 3

Polymer‐Encapsulated Catalase for Targeted Redox Regulation in Acute Liver Injury
Feifei Li, Sai Gao, Rui Ma, et al.
Small (2025)
Closed Access

Mifepristone induced liver injury in a patient with Cushing syndrome: a case report and review of the literature
Taylor A. Ault, David R. Braxton, Rebecca A. Watson, et al.
Journal of Medical Case Reports (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 8

Post-COVID-19 cholangiopathy: Current understanding and management options
Fadl H. Veerankutty, Kushan Sengupta, Mukul Vij, et al.
World Journal of Gastrointestinal Surgery (2023) Vol. 15, Iss. 5, pp. 788-798
Open Access | Times Cited: 7

Drug-induced liver injury in COVID-19 treatment: Incidence, mechanisms and clinical management
Xichuan Li, Wanting Wang, Suying Yan, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 10

Acute-on-chronic liver failure in patients with severe acute respiratory syndrome coronavirus 2 infection
Péter Lipták, Lenka Nosáková, Róbert Rosoľanka, et al.
World Journal of Hepatology (2023) Vol. 15, Iss. 1, pp. 41-51
Open Access | Times Cited: 6

SARS-CoV-2 induced liver injury: Incidence, risk factors, impact on COVID-19 severity and prognosis in different population groups
George D. Liatsos
World Journal of Gastroenterology (2023) Vol. 29, Iss. 16, pp. 2397-2432
Open Access | Times Cited: 5

Age-dependent immune responses in COVID-19-mediated liver injury: focus on cytokines
Nazanin Aghamohamadi, Faezeh Shahba, Ali Zarezadeh Mehrabadi, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 5

COVID-19-Associated Liver Injury
Daniel T Gildea, Stephanie Woo, Corinne E O'Connor, et al.
Hepatic Medicine Evidence and Research (2023) Vol. Volume 15, pp. 1-9
Open Access | Times Cited: 4

COVID-19 and the Liver: A Complex and Evolving Picture
Simon D. Taylor‐Robinson, Marsha Y. Morgan
Hepatic Medicine Evidence and Research (2023) Vol. Volume 15, pp. 209-220
Open Access | Times Cited: 4

The Synergistic Effect of Huangqi Gegen Decoction on Thrombosis relates to the Astragalus Polysaccharide-improved Oral Delivery of Puerarin
Yi Zhang, Jiaxuan Zhang, Liang-Xing Xiao, et al.
Journal of Ethnopharmacology (2024) Vol. 335, pp. 118622-118622
Closed Access | Times Cited: 1

COVID-19, Possible Hepatic Pathways and Alcohol Abuse—What Do We Know up to 2023?
Agata Michalak, Tomasz Lach, Karolina Szczygieł, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2212-2212
Open Access | Times Cited: 1

Portal Hypertension in Alcohol-Associated Hepatitis
Matthew J. McConnell, Yasuko Iwakiri
Current Hepatology Reports (2023) Vol. 22, Iss. 2, pp. 67-73
Open Access | Times Cited: 3

Current Views About the Link between SARS-CoV-2 and the Liver: Friends or Foe?
Roberto Lovero, Ioannis Alexandros Charitos, Skënder Topi, et al.
Endocrine Metabolic & Immune Disorders - Drug Targets (2023) Vol. 24, Iss. 6, pp. 642-650
Closed Access | Times Cited: 3

Page 1 - Next Page

Scroll to top